MAP2K7 and non-small cell lung carcinoma: From our previous comparison of SCLC and NSCLC [4], we would consider SCLC with more active MEK/ERK signaling to be closer to the NSCLC end of the spectrum of SCLC, perhaps explaining why these cells are less sensitive to BKM-120.